CD8A and neoplasm: Our data indicate that both BH3 mimetics, when simultaneously combined with CAR-T cells, not only impaired the repetitive tumor killing potential of CAR-T cells and the long-term cytotoxicity, but also hampered the early proliferation of both CD4+ and CD8+ CAR-T cells.